Insights On CONTRACT PHARMA MANUFACTURING

  1. Removing Cost Barriers To Scalable AAV Manufacturing 5/7/2026

    Alternative AAV manufacturing approaches can dramatically reduce cost per dose, improve scalability, and increase yields across serotypes, enabling broader patient access to gene therapies.

  2. Improving LVV And AAV Yield Through Cargo Gene Silencing 5/7/2026

    Silencing cargo gene expression during LVV and AAV production improves cell health, reduces impurities, and significantly increases vector yield for cytotoxic and difficult‑to‑manufacture transgenes.

  3. Asymchem Group – A Fully Integrated CDMO Partner For The Global Pharmaceutical Industry 5/7/2026

    Smarter chemistry and process design enable sustainable manufacturing. Modern methods reduce waste and energy use while maintaining efficiency and high‑quality pharmaceutical production.

  4. From Clinical To Commercial: Asymchem's Cartridge Filling Capabilities In 30s 5/7/2026

    Automated cartridge filling and integrated manufacturing help reduce risk, simplify scale‑up, and support a smoother transition from clinical development to commercial production.

  5. The TIDES Manufacturing Mandate: Why Incrementalism Fails And Integration Prevail 5/7/2026

    Manufacturing strategies for peptides and oligonucleotides are being reshaped by scale, complexity, and chronic use. An integrated, end‑to‑end approach shows how early design decisions can prevent costly bottlenecks later.

  6. How Dermal Delivery Platforms Are Transforming Tomorrows For Patients 5/7/2026

    Skin delivery platforms expand therapies by boosting convenience, stability, and adherence. Integrated formulation, device, and manufacturing development is key to confidently scale.

  7. Early Developability Assessment For Antibody Based Therapeutics 5/7/2026

    Learn how an integrated developability and immunosafety toolbox can help de-risk multi-specific antibody development, improve candidate selection, and accelerate complex biologics toward the clinic.

  8. The Analytical Advantage Across The Development Lifecycle 5/7/2026

    Integrated, regulatory‑ready analytics help accelerate development, strengthen submissions, and ensure consistent product quality throughout the pharmaceutical lifecycle.

  9. Development Of A Unique And First-Of-Its-Kind Flow Photo Reactor – CSCPR 5/6/2026

    A novel circular LED‑based flow photoreactor delivers uniform light intensity, improved energy efficiency, rapid residence times, and scalable throughput for greener, high‑performance photochemical bromination processes.

  10. Enhancing Gene Editing Outcomes And Safety for Clinical Translation With Next Generation Vectors 5/6/2026

    Learn how streamlined vector backbones can improve efficiency, consistency, and expression durability when reliability matters most.